Bank Of America Corp Onconova Therapeutics, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.57 - $1.0 $119 - $209	209 New	209 $0
Q4 2023 Feb 14, 2024	BUY	$0.62 - $0.79 $400 - $510	646 Added 1957.58%	679 $0
Q1 2023 May 12, 2023	SELL	$0.69 - $1.42 $16 - $34	-24 Reduced 42.11%	33 $0
Q4 2022 Feb 10, 2023	BUY	$0.63 - $0.97 $15 - $23	24 Added 72.73%	57 $0
Q4 2021 Feb 08, 2022	SELL	$2.49 - $3.73 $961 - $1,439	-386 Reduced 92.12%	33 $0
Q3 2021 Nov 15, 2021	BUY	$3.81 - $6.76 $1,447 - $2,568	380 Added 974.36%	419 $1,000
Q2 2021 Sep 13, 2021	BUY	$6.28 - $16.2 $244 - $631	39 New	39 $0

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.